Announcements Trials

Browse Landscape

Status

Completed 5 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 4 Gynecologic 2 Genitourinary 2 Dermatologic 2 Thoracic 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Gastrointestinal 1 Breast 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 133 Cisplatin 130 Pemetrexed 114 Docetaxel 79 Drug Therapy 61 Gefitinib 57 anlotinib 55 Gemcitabine 55 Erlotinib Hydrochloride 55 Radiotherapy 48 Bevacizumab 48 pembrolizumab 47 Paclitaxel 47 Etoposide 44 apatinib 42 icotinib 41 camrelizumab 39 osimertinib 35 Vinorelbine 31 Nivolumab 31 Radiosurgery 30 sintilimab 29 aumolertinib 25 endostar protein 24 durvalumab 24 atezolizumab 23 Endostatins 22 Blood Specimen Collection 19 toripalimab 18 Immune Checkpoint Inhibitors 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Data Collection × Thoracic × Clear all

NCT05783024 2023-05-10

ADAMpartlung

AZ Delta

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡